Abstract
Acrylamide, 779
Activity-generated cytoskeleton-associated protein (Arc), 691
Acute hepatic failure (AHF), 541
Acute kidney injury (AKI), 1363
Acute liver failure, 73
Acute lung injury (ALI), 1699, 2629
Adipocyte regeneration, 49
Adipogenesis, 1969
Adipose-derived stem cells (ADSCs), 493, 521, 533, 1753, 2323
Adipose mesenchymal stem cells, 2573
Adipose stem cells, 939
Adipose stromal vascular fraction, 2029
Adipose tissue, 63, 2297
Adipose tissue-derived mesenchymal stem cells, 2221, 2307
Adipose tissue-derived stem cells (ADSCs), 487
Adipose tissue-derived, platelet-derived growth factor receptor β-positive (AT-PDGFRβ+) cells, 1469
Adult neurogenesis, 377
Adult stem cells, 203
Advanced therapy medical product (ATMP), 2171
Akt, 1031
Alginate, 247
Alloantigen, 2527
Allodepletion, 1167
Allogeneic mesenchymal stem cells (MSCs), 2643
Allograft, 2143
Allograft tolerance, 2129
Alu repeat sequences, 1639
Alzheimer's disease (AD), 487, 1097
Amnion, 2601
Amnion epithelial stem cells, 2065
Amnion mesenchymal stem cells, 2065
Amnion stromal extract (ASE), 1845
Amniotic epithelial cells (AECs), 985, 1733, 2055
Amniotic fluid-derived progenitor cells (ADPCs), 1003
Amniotic mesenchymal stromal cells, 1733
Amotosalen, 1545
Amyloid β, 2237
Amyotrophic lateral sclerosis, 487, 599
Anal sphincter, 277
Anaplastic astrocytoma (AA), 1431
Angiogenesis, 85, 223, 955, 1363, 1481, 1571, 1585, 1653, 2323, 2353
Angiotensin-converting enzyme 2 (ACE2), 1699
Animal behavior, 703
Animal models, 349
Antiapoptosis, 2463
Antigen presentation, 599
Anti-inflammation, 521
Apoptosis, 1155, 1363
Articular cartilage, 1053, 1661
Astrocytes, 115, 377, 599
ATP, 1183
Autoimmune diabetes, 1599
Autoimmune disease, 2221
Autoimmune thyroiditis, 2221
Autoimmunity, 2285
Autologous, 1085
Autologous adherent bone marrow derived cell therapy, 1813
Autologous cell therapy, 1205
Autologous graft, 63, 2297
Autologous islet transplantation (ITx), 1615, 2285
Automated digital image analysis (AIDA), 1
Autophagy, 419
Axon regeneration, 115
Axonal regeneration, 1829
5-Azacytidine, 2307
B1BKR and B2BKR, 613
B-Cell CLL/lymphoma 2 (Bcl-2) adenovirus E1B 19-kDa interacting protein 3 (BNIP3), 561
B-Cell lymphoma extra large (Bcl-xL), 1127
B-Cell regeneration, 879
B Cells, 2155
Biodistribution, 819, 1945
Bioenergetics, 2491
Biomaterials, 247
Biomechanical test, 509
Bladder, 1679
Bladder fibrosis, 1253
Blood pressure (BP), 1901
Blood vessels, 2209
Blood–brain barrier (BBB), 377, 1469
BM-MSC mobilization, 865
Bone fracture, 1379
Bone marrow cells (BMCs), 167
Bone marrow-derived mesenchymal cells (BM-MSCs), 819
Bone marrow-derived stem cells (BMSCs), 1753
Bone marrow-derived stromal cell transplantation, 1945
Bone marrow (BM) insufficiency, 349
Bone marrow mesenchymal stem cells (BMSCs), 391, 1265, 1957
Bone marrow mononuclear cells, 955
Bone marrow stem cells, 879
Bone marrow stromal cells (BMSCs), 1283, 2209
Bone marrow transplantation (BMT), 879, 1931
Bone mesenchymal stem cells (BMSCs), 1533
Bone morphogenetic protein 13 (BMP13), 909
Bone morphogenetic protein 9 (BMP9), 909
Bone tissue engineering, 1945, 1957
Bradykinin, 613
Brain, 223, 921
Brain death, 1863
Brain-derived neurotrophic factor (BDNF), 2209, 2449
Brain transplantation, 191
Brain tumor, 625
Bronchopulmonary dysplasia, 85
C3H10T1/2 cells, 909
Calcium phosphate, 1767
Canine, 1469, 1813
Canine bone marrow stem cells, 1969
Cardiac differentiation, 2463
Cardiac-like differentiation, 2307
Cardiac regeneration, 1013, 2409
Cardiomyocytes (CMs), 561, 909, 1653, 2491
Cardiomyopathy, 1043
Cardiospheres (CSs), 2307
Caudate nucleus, 673
Caveolin, 1395
Cavernous nerve injury, 487
C-C-motif ligand 22 (CCL22), 263
CD8lowCD28- T cells, 2129
CD133, 2409
CD137, 1167
CD34+ cells, 1379
CD83, 1395
Cell adhesion, 1767
Cell-based delivery, 2323
Cell-based therapy, 2513
Cell culture, 287
Cell density, 1945
Cell differentiation, 631
Cell engineering, 797
Cell labeling, 2185
Cell lineage, 313
Cell migration, 2423
Cell proliferation, 1481
Cell replacement, 1451
Cell seeding, 1945
Cell sheet, 2479
Cell signaling pathways, 721
Cell suspension, 737
Cell therapy, 37, 49, 183, 277, 661, 985, 1013, 2077, 2527, 2541
Cell tracking, 1111, 2379
Cell transplant, 1139
Cell transplantation, 287, 737, 1003, 1299, 1379, 1481, 1679, 1799
Central pattern generator (CPG), 429
Cerebral ischemia, 819
Cerebral palsy (CP), 471
Chemical diabetes, 879
Chemokines, 1067, 2143
Chondrocytes, 1053
Chondrogenesis, 1053, 1221, 1969
Chondrogenic progenitors, 1053
Chronic liver disease, 1627
c-kit, 85
Clinical application, 339
Clinical treatment, 533
Clinical trial, 1901
Coculture, 645
Cold ischemia, 25
Colitis, 2601
Collagen tube, 213
Compensatory mechanism, 673
Conditioned media (CM), 1031, 2307
Conditioned medium (CM), 2657
Connexin 36, 37
Contact hypersensitivity response (CHSR), 573
Cord blood, 97, 305, 2237
Cornea, 287, 1845, 2423
Corneal endothelial cell transplant, 1915
Corneal neovascularization, 1915
Cornu ammonis 1 (CA1), 367
Costal chondrocytes, 235
Costimulatory molecules, 1599
Cryopreservation, 305, 1139
Cryopreserved hepatocytes, 2557
Crystallins, 1829
CTLA4Ig, 2221
Cultured melanocytes, 1423
CXC chemokine receptor 4 (CXCR4) antagonist, 1313
Cyclin D2 knockout, 2435
Cyclosporin A, 2513
Cytokines, 1585, 2055, 2285
Dedifferentiation, 1585
Dendritic cells (DCs), 573, 1395, 1733, 2527
Dental pulp stem cells (DPSCs), 97
Dental pulp stem/progenitor cells, 1753
Dermis, 1405
Diabetes, 37, 263
Diabetes mellitus, 1571, 2143, 2155
Diazoxide (DZ), 25
Differentiation, 313, 645, 1265, 1545, 2423
Diffusion tensor MR imaging, 971
Digital image analysis (DIA), 1195
3,2′-Dihydroxyflavone, 1511
Displacement encoding, 971
DNA delivery, 2185
DNA plasmid, 263
Dog, 2221
Dog breeds, 1969
Donor management, 1863
Donor-specific antibodies, 811
Dopamine, 673, 2113
Dopamine reuptake, 2113
Dopaminergic cells, 2251
Dopaminergic (DA) neurons, 1451, 2099
Dose–effect relationship, 1957
Doxorubicin (DOX), 1031, 1043
Drug delivery system, 2513
Ectopic bone yield, 1957
Electric stimulation (ES), 419
Electrical stimulation, 1653
Electroacupuncture, 1265
Embryonic fibroblasts, 223
Embryonic neural progenitor cells (NPCs), 1829
Embryonic stem cells (ESCs), 471, 561, 829, 845, 1031, 1043
Endocytosis, 1395
Endothelial progenitor cells (EPCs), 37, 1343, 1363
Engineered skin, 1423
Engraftment, 2263, 2541, 2557
Engraftment analysis, 1639
Enhanced green fluorescent protein (eGFP) transfection, 1451
Enhancer of zeste homolog 2 (EZH2), 313
Enriched environment, 2435
Ependymal cells, 1493
Ephrin B, 1343
Epithelial-to-mesenchymal transition (EMT), 2585
Ethylene carbodiimide (ECDI), 1155
Exosomes, 133
Experimental model, 277
Extracellular matrix, 2557
Extracellular vesicles (EVs), 2615
Extramedullary hematopoiesis (EMH), 349
Extramedullary hematopoietic niche, 349
Fas, 1329
Fas ligand (FasL), 1329
Fast-scan cyclic voltammetry (FSCV), 2113
Fat particles, 1233
Fat transplantation, 49
Fecal incontinence (FI), 277
Fertility preservation, 1999
Ferumoxide (iron oxide), 183
Fetal hepatocytes, 1627
Fetal membrane-derived stromal cells, 223
Fetal striatal tissue, 811
Fiber architecture, 971
Fibroblast and keratinocyte migration, 865
Fibroblast growth factor 2 (FGF2), 319
Fibronectin, 1767
Fibrosis, 2657
Fluid percussion injury, 2113
FNK, 1127
Focal cerebral ischemia, 183
Follicle survival, 1999
Follicular helper T cells (Tfh cells), 2367
Fracture healing, 2643
Functional electrical stimulation (FES), 429
G-CSF, 865
Gene, 2197
Gene activation, 1233
Gene expression, 721
Gene expression profile, 151
Gene therapies, 521
Gene therapy, 625, 891, 1699, 2209
Gerbil, 367
Glia, 599
Glioblastoma multiforme (GBM), 631
Gliotransmitter, 599
Glucose tolerance, 1615
Glucose-stimulated insulin secretion, 1615, 2505
Graft apoptosis, 1481
Graft-versus-host disease (GVHD), 1167, 1717, 2527
Graft-versus-leukemia (GVL) effect, 1167
Granulocyte-colony-stimulating factor (G-CSF), 447, 1085, 1753
Growth factor, 2197
Hair follicles, 891
HbA1c, 1879
Heart failure, 2337
Heatstroke, 921
Hematopoietic cells, 1405
Hematopoietic progenitors, 879
Hematopoietic stem and progenitor cells (HSPCs), 349
Hematopoietic stem cells, 2409
Hematopoietic stem cell transplantation, 151
Hematopoietic stem/progenitor cells, 97
Hepatic progenitor cells, 1639
Hepatic stellate cells (HSCs), 2557
Hepatocyte, 1127
Hepatocyte growth factor (HGF), 541
Hepatocyte transplantation, 73
Hes-1, 645
Heterodimerization, 2237
Heterologous, 203
HIF-1α, 2353
Hippocampus, 691
Homing, 2629
Human, 645, 1183
Human adipose-derived stem cells (hADSCs), 509
Human bone marrow stromal cells (hBMSCs), 2423
Human cord blood, 2573
Human cord blood cells, 2099
Human corneal endothelial cells (hCECs), 287
Human embryonic germ (hEG) cells, 471
Human embryonic stem cells (hESCs), 2155
Human exfoliated deciduous teeth pulp stem cells, 921
Human fetal hepatocytes, 1139
Human fetal liver cell transplantation (hFLCTx), 1627
Human hepatocytes, 2541
Human induced pluripotent stem cells, 1781
Human islets, 1, 2505
Humanized rodent model, 521
Human mesenchymal stem cells (hMSCs), 1253, 2463
Human neural stem cell (hNSCs), 183, 191, 691
Human pancreatic duct cell, 1585
Human peripheral blood, 2573
Human placenta, 1733
Human umbilical cord blood (HUCB), 721
Human umbilical mesenchymal stem cells (HUMSCs), 2251
Huntington's disease, 487, 811
Hyaline cartilage, 235
Hyaluronan, 1221
Hydrogel, 541
Hyperosmolar mannitol, 1469
Hyperoxia, 85
Hypophosphatasia (HPP), 1931
Hypopigmentation, 1423
Hypothermic preservation, 2541
Hypoxia, 561, 2323
Hypoxic-ischemic (HI) stroke, 2449
IL-1 receptor antagonist, 1863
IL-8, 1067
IL-10, 2065
Immobilization, 591
Immortalization, 1053
Immune privilege, 845
Immune rejection, 1013
Immune response, 1481
Immunity, 133
Immunogenicity, 845
Immunomodulation, 223, 1313, 1555, 1733, 2077, 2615
Immunomodulatory, 521
Immunomodulatory and immunosuppressive activity, 151
Immunosuppressant, 1585
Immunosuppression, 263, 573, 1799
Immunosuppressive activity, 2065
Immunosuppressive drugs, 1155
Immunotoxin, 1167
Implantation instrument, 737
In vitro differentiation, 2099
In vivo, 2379
Induced pluripotent stem cells (iPSCs), 471, 541, 845, 1127, 1799, 2099, 2185, 2479, 2491
Inducible costiumlator (ICOS), 1717
Inflammation, 167, 457, 613, 703, 1313, 1863, 2285
Infrapatellar fat pad, 1221
Innate immunity, 1863
Innervation, 797
Instant blood-mediated inflammatory reaction (IBMIR), 2505
Insulin, 1183
Insulin-producing cells (IPCs), 521, 879, 1555
INTERCEPT, 1545
Interface, 115
Interleukin-1β (IL-1β), 2011
Interleukin-6 (IL-6), 2585
Interleukin-8 (IL-8), 2585
Interleukin-10 (IL-10), 1013, 2367
Intervertebral disk regeneration, 2197
Intra-arterial (IA) delivery, 819
Intra-arterial injection, 1469
Intramuscular transplantation, 263
Intranasal, 391
Intrastriatal transplantation, 2099
Intrathecal, 1813
Intravascular transplantation, 2449
Ion channel current, 909
Irisflorentin, 573
Iron chelator, 2353
Ischemia, 167, 457, 721, 1363
Ischemic, 1571
Ischemic heart, 1329
Ischemic heart injury, 971
Ischemic preconditioning (IPC), 367, 1901
Islet, 1183, 2273
Islet cell transplantation, 1155
Islet engraftment, 11
Islet equivalent (IEQ), 1183
Islet fragmentation, 11
Islet functionality, 11
Islet isolation, 25, 1879
Islet overdigestion, 11
Islet purity, 1195
Islet quantification, 1195
Islet remodeling, 879
Islet size, 11
Islets of Langerhans, 37
Islet surface area, 1
Islet transplantation, 25, 37, 247, 1195, 1585, 1599, 1863, 2143, 2263
Isolation, 2273
Kidney, 1687
Kupffer cells, 1155
Laminin (LN), 247, 2435
Large animal model, 1205
Lentivirus, 891
Leukemia inhibitory factor (LIF), 319
Literature review, 1679
Liver, 2541
Liver cirrhosis, 533
Liver fibrosis, 493
Liver function, 1139
Local injection, 2643
Locomotion recovery, 1493
Losartan, 939
Lung repair, 2629
Lycium barbarum, 403
Lycium barbarum polysaccharide (LBP), 419
Macrophage(s), 403, 2601
Magnetic nanoparticle (MNP), 191
Magnetic resonance imaging (MRI), 191, 1111, 2285, 2337, 2391
Magnetic targeting intensity, 1981
Magnet targeting, 183
Major histocompatibility complex (MHC), 845
Mechanical fragmentation, 1233
Membrane-bound TGF-b1, 2129
Mesenchymal stem cells (MSCs), 73, 133, 471, 631, 661, 891, 1067, 1097, 1233, 1313, 1329, 1405, 1555, 1571, 1661, 1699, 1717, 1981, 1999, 2077, 2367, 2585, 2601, 2629, 2657
Mesenchymal stem cell (MSC) transplantation, 1931
Mesenchymal stem/stromal cells (MSCs), 97, 2615
Mesenchymal stromal cells (MSCs), 865, 1545, 1687, 2391
Mesenchymal stromal stem cells (MSCs), 645
Mesoporous silica nanoparticle, 2185
Microembolization, 1981
Microencapsulation, 247
Microglia injury, 419
MicroRNA (miRNA), 367, 1431
Microvesicles, 133
Middle cerebral artery (MCA) stenosis, 1901
MIP-3α, 1067
Mitogen-activated protein kinase (MAPK), 573
Mitoprotection, 25
Model for End-Stage Liver Disease (MELD) score, 1627
Monocyte(s), 1733, 2237
Monolayer expansion, 235
Mononuclear cells (MNCs), 1379
Morphology, 599
Motor neurons, 797
Motor recovery, 429
Mouse model, 2463
MPTP, 673
Multiple organs, 921
Multiple sclerosis (MS), 151, 599, 1265, 2077
Multipotent mesenchymal stromal cells (MSCs), 151
Multipotent stromal cells (MSCs), 1111, 2379
Murine model islet transplant, 11
Muscle, 263
Muscle physiologic functions, 1887
Muscle regeneration, 1887
Muscular dystrophy, 939
Myoblast(s), 277, 1887
Myocardial infarction (MI), 985, 1003, 1013, 1313, 1981, 2055, 2337, 2463
Myocardial wall strain, 971
Myocardium, 2041
Myosin light chain kinase (MLCK), 2011
Nanomedicine, 1915
Necrosis, 1155
Neonate, 391
Neovascularization, 1043
Nerve graft, 213
Nerve regeneration, 203
Neural cell adhesion molecule (NCAM), 779
Neural crest stem cells, 1405
Neural differentiation, 613
Neural induction (NI), 829
Neural phenotype, 1233
Neural precursors (NPs), 1781
Neural progenitor cells, 829, 2435
Neural progenitors, 2263
Neural proliferation, 167
Neural stem cells (NSCs), 471, 645, 681, 703, 2449
Neural stem/progenitor cells (NSPCs), 779
Neural transplantation, 811
Neurogenesis, 591, 599, 1097, 2435
Neuroglycan (NG2), 115
Neuroinflammation, 447, 599
Neurological disorders, 591
Neurologic severity scores, 921
Neuronal differentiation, 1781
Neuroprotection, 613, 2209
Neuroprotective property, 1511
Neuroregeneration, 1781
Neurosphere formation, 779
Neurospheres, 1233
NF-κB, 2601
NOD mice, 1555
NOD-SCID, 1879
Nonhuman primate (NHP), 191
Nonobese diabetic (NOD) mice, 2011
Nonunion, 1379
Nonviral vector, 1431
Notch-1, 645
Novel-object recognition (NOR) test, 2113
Nuclear erythroid 2-related factor 2 (Nrf2), 2273
Nuclear factor-κB (NF-κB), 573
Nuclear localization signal (NLS), 1431
Nurr1, 2251
Ocular graft-versus-host disease (oGVHD), 2423
Olfactory ensheathing cells (OECs), 1533
Optic nerve (ON), 403
Optic nerve crush, 1829
Osteoarthritis (OA), 1053, 1085, 1661, 2379, 2391
Osteoarthritis Research Society International (OARSI), 2391
Osteogenesis, 1931, 1969
Ovarian cortex transplantation, 1999
Ovarian cryopreservation, 1999
Ovine model, 2391
Oxidative stress, 2273
Pancreas preservation, 25
Pancreatic islet, 2155
Pancreatic islet transplantation, 2285
Pancreatogenic diabetes, 1615
Paracrine, 2055
Parkinson's disease (PD), 487, 673, 681, 1451, 2099, 2251
Parthenogenetic stem cells, 681
Partial pancreatectomy, 1615
Partial transection, 403
Patch clamp technique, 1451
Pathogen inactivation, 1545
Periodontium, 1767
Peripheral blood stem cells, 1085
Peripheral nerve injury model, 1511
PGE2, 2065
Pharmacological properties, 1493
Physical exercise, 591
PI3K/AKT, 2353
Pig, 1003
Pig model, 2463
Placenta, 457, 2463
Platelet, 1545
Platelet gel, 2573
Platelet lysate, 1545
Pluripotent stem cell, 845, 1511
Polycystic kidney disease (PKD), 1687
Polysialylation, 797
Porcine bone marrow mesenchymal stromal cells, 1205
Portosystemic encephalopathy (PSE), 1627
Preclinical trial, 1085
Preservation, 2409
Pretreatment, 2449
Primary cultures, 1139
Primate, 673
3D printing, 2513
Proangiogenesis, 2463
Progenitor cells, 2041
Progenitors of smooth muscle cells, 1343
Proinsulin, 2505
Proliferation, 1845
Promonocyte, 955
Protein kinase C (PKC) signaling, 2011
Proteome array, 2573
Pulp/dentin regeneration, 1753
Purinergic receptors, 1493
Quality, 305
Quantitative polymerase chain reaction (qPCR), 1639
Rabbit embryonic stem cells (rESCs), 319
Radiation, 691, 1343
Rat model, 1981
Reactive astrogliosis, 599
Reactive oxygen species, 2273
Recovery neurobiology, 2197
Refractory angina, 955
Refractory angina cell therapy, 955
Regeneration, 391, 1283
Regeneration medicine, 1915
Regeneration therapy, 2479
Regenerative medicine, 313, 703, 1423
Regulatory B cells (Bregs), 2367
Regulatory cells, 1599
Regulatory T cells (Tregs), 2143, 2527, 2615
Reinnervation, 2263
Remyelination, 1813
Renal function, 1687
Renal hypertension, 2041
Repair, 2657
Retention, 2629
Revascularization, 2263
Rostral migratory stream (RMS), 377
Rotator cuff injury, 509
Salvianolic acid B (Sal-B), 561
Scaffold, 1283
Schwann cells (SCs), 115
Sciatic nerve, 213
SCID-repopulating cells, 97
Secondary degeneration, 403
Sedimentation, 737
Self-assembly, 235
Self-renewal, 319, 1511
Senescence, 493, 631
Settling, 737
Silent mating type information regulation 2 homolog (SIRT1), 493
Single-photon emission computed tomography (SPECT) imaging, 819
Skeletal muscle regeneration, 939
Skin-derived stem cells (SDSCs), 213
Skin regeneration, 865
Sodium chlorate, 2155
Soluble amyloid precursor protein a (sAPPa), 2237
Soluble HLA-A2 dimer, 2129
Spheroid culture, 2323
Spinal cord injury (SCI), 115, 429, 661, 703, 1253, 1283, 1299, 1493, 1781, 1799, 1813, 2209
Spinal glioblastoma, 1299
Standard manual method, 1
Stem cell imaging, 2171
Stem cell labeling, 2171
Stem cell microenvironment, 939
Stem cell migration, 2011
Stem cell niche, 377
Stem cells, 63, 85, 313, 339, 447, 457, 591, 625, 797, 1221, 1767, 1901, 1915, 2041, 2197, 2263, 2297
Stem cell therapy, 533, 2171
Stem cell transplantation, 865
Stem-like cancer cells, 631
Stemness, 645
Stem/progenitor cells, 1493
Stress urinary incontinence (SUI), 2171
Stroke, 167, 391, 487
Stromal keratocytes, 1845
Stromal vascular fraction (SVF) cells, 49
Subconjunctival injection, 2423
Subcutaneous adipose-derived stem cells, 2337
Superparamagnetic iron oxide (SPIO) particles, 1111, 2285, 2379
Suppressor T cells, 2129
Surface treatment, 1767
Surgical cannula, 737
Synaptic formation, 429
Synchrotron imaging, 2479
Syngeneic cell transplantation, 1887
Systemic injection, 2643
Systemic lupus erythematosus (SLE), 2367
Systemic sclerosis (SSc), 63, 2297
Tacrolimus, 1799
T-cell mediated rejection, 2513
Tendon, 509
Th1/Th2/Th17 polarization, 1717
Therapeutic angiogenesis, 2029
Therapy response, 631
Thermoregulation, 921
3D printing, 2513
Three-dimensional culture, 235
Tissue engineering, 203, 287, 1053, 1661, 1679
Tissue factor (TF), 2505
Tolerance, 1155, 2143
Trafficking, 599
Transforming growth factor-β1 (TGF-β1), 985
Transplantation, 115, 203, 223, 457, 625, 661, 691, 703, 797, 1127, 1283, 1329, 1395, 1423, 1533, 1879, 2077, 2251, 2273, 2409, 2435, 2541, 2557
Transplantation centers, 1
Traumatic brain injury (TBI), 447, 1533
Trophic effect, 1753
Trophic support, 1781
Tumorigenicity, 1423
Type 1 diabetes, 521, 891, 1205, 2491
Type 1 diabetes mellitus, 247
Type 1 diabetes patients, 2285
Type 2 diabetes, 1879
Tyrosine hydroxylase (TH), 673
Tyrosine receptor kinase C (TrkC), 1265
UCX®, 865
Ulcers, 2297
Umbilical cord, 339
Umbilical cord blood (UCB) cells, 471
Umbilical cord blood stem cells, 971
Unilateral ureteral obstruction (UUO), 2657
Urology, 1679, 2171
Vascular endothelial growth factor (VEGF), 1653
Vasculature, 377, 1687
Vasculogenesis, 2029, 2353
Vesicles, 599
Viability, 1183
Visceral adipose-derived stem cells, 2337
Wharton's jelly, 339, 1555, 2077
Wnt, 829
Wnt signaling pathway, 1097
Wound healing, 1343
Xenografting, 819
Xenograft model, 1299
Xenotransplantation, 97, 1639
X-linked myotubular myopathy (XLMTM), 1887